nLc4sph (d18:1) is a glycosphingolipid subtype that can be used as a reference substance in the research of the pathogenesis of cardiovascular diseases.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
